Bausch Health Companies | VRX - Pre Tax Profit

Stock Price
8.03
Daily Change
0.19 2.42%
Monthly
-26.67%
Yearly
-13.00%
Q1 Forecast
7.62

Bausch Health Companies reported $218M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Amgen USD 3.92B 2.35B Sep/2025
ANI Pharmaceuticals USD 49.52M 39M Sep/2025
Aurora Cannabis CAD 46.98M 66.36M Sep/2025
Bausch Health Companies USD 218M 78M Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Canopy Growth CAD -1.42M 39.82M Sep/2025
Corcept Therapeutics USD 15.24M 16.45M Sep/2025
Danaher USD 1.08B 421M Sep/2025
Drreddys Laboratories INR 15.43B 1.96B Dec/2025
Eli Lilly USD 7.23B 456M Sep/2025
Gilead Sciences USD 2.43B 780M Jun/2025
Novo Nordisk DKK 33.8B 3.23B Jun/2025
Pacira USD -1.93M 10.63M Jun/2025
Perrigo USD 22.4M 19.2M Sep/2025
Prestige Brands USD 69.13M 7.35M Sep/2025
Supernus Pharmaceuticals USD -57.95M 74.62M Sep/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025
Zoetis USD 887M 15M Sep/2025